Q2 2025
Released Aug 14, 2025, after the close
10-Q filed Aug 14, 2025, 45 days after period end · 0000950170-25-109041
Q2 2025 · 10-Q
Revenue$134.60K$134.60K no prior Q2 2024 on fileno prior Q1 2025 on file
Net Income-$3.28M-$3.28M N/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$0.07-$0.07 N/M vs Q2 2024N/M vs Q1 2025
Operating Income-$3,607,092N/M
Operating Cash Flowderived-$2,306,406N/M
Free Cash Flowderived-$2,306,406—
Margins · derived
Operating margin-2679.9%
Net margin-2437.7%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2025 | Q2 2024 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $134.60K | — | — | — |
| Net Income | -$3.28M | -$2.63M | -$4.45M | -$3.88M |
| EPS Diluted | -$0.07 | -$0.05 | -$0.10 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR